Trial intelligence / Profile preview

RE-ELECT: Dabigatran vs Warfarin in AF with T2DM and CKD

NCT03789695Phase 4Unknown

Start
Nov 2018
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dabigatran in Atrial fibrillation (AFib). Status: unknown.

02

Drugs

dabigatran
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT03789695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03789695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call